Informações:
Falhas:
ID
21993
Descrição
Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b; ODM derived from: https://clinicaltrials.gov/show/NCT00942591
Link
https://clinicaltrials.gov/show/NCT00942591
Palavras-chave
Versões (1)
- 13/05/2017 13/05/2017 -
Transferido a
13 de maio de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Multiple Sclerosis NCT00942591
Eligibility Multiple Sclerosis NCT00942591
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis NCT00942591
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Relapsing-Remitting Multiple Sclerosis Subtypes
Item
patients with relapsing-remitting forms of multiple sclerosis (according to mcdonald's criteria)
boolean
C0751967 (UMLS CUI [1,1])
C0872379 (UMLS CUI [1,2])
C0872379 (UMLS CUI [1,2])
Relapse Quantity
Item
at least 1 relapse in the past two year
boolean
C0035020 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
Lesion Quantity MRI of Spinal Cord | Lesion Quantity MRI brain procedure
Item
> 3 lesions on spinal or brain-mri
boolean
C0221198 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C2454646 (UMLS CUI [1,3])
C0221198 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0412675 (UMLS CUI [2,3])
C1265611 (UMLS CUI [1,2])
C2454646 (UMLS CUI [1,3])
C0221198 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0412675 (UMLS CUI [2,3])
Kurtzke multiple sclerosis rating scale
Item
edss score between 0 and 3.5, inclusive
boolean
C0451246 (UMLS CUI [1])
Age
Item
age between 18 and 55 years
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Gender Pregnancy test negative
Item
negative pregnancy test results (all women)
boolean
C0079399 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
C0427780 (UMLS CUI [1,2])
Disease Explanation Signs and Symptoms | Multiple Sclerosis
Item
any disease other than multiple sclerosis that would better explain the patient's signs and symptoms
boolean
C0012634 (UMLS CUI [1,1])
C0681841 (UMLS CUI [1,2])
C0037088 (UMLS CUI [1,3])
C0026769 (UMLS CUI [2])
C0681841 (UMLS CUI [1,2])
C0037088 (UMLS CUI [1,3])
C0026769 (UMLS CUI [2])
Multiple Sclerosis, Primary Progressive
Item
primary progressive ms
boolean
C0751964 (UMLS CUI [1])
Multiple Sclerosis, Secondary Progressive
Item
secondary progressive ms
boolean
C0751965 (UMLS CUI [1])
Disease Severe Uncontrolled
Item
uncontrolled severe medical disorder
boolean
C0012634 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
Drug abuse
Item
a history of drug abuse in the 6 months prior to screening
boolean
C0013146 (UMLS CUI [1])
Monoclonal Antibody Therapy | Mitoxantrone | Cytotoxic therapy | Therapeutic immunosuppression | Steroids
Item
previous therapy with monoclonal antibodies, mitoxantrone, cytotoxic or immunosuppressive therapy (except steroids)
boolean
C0279694 (UMLS CUI [1])
C0026259 (UMLS CUI [2])
C0677881 (UMLS CUI [3])
C0021079 (UMLS CUI [4])
C0038317 (UMLS CUI [5])
C0026259 (UMLS CUI [2])
C0677881 (UMLS CUI [3])
C0021079 (UMLS CUI [4])
C0038317 (UMLS CUI [5])
Study Subject Participation Status
Item
participation in any other studies
boolean
C2348568 (UMLS CUI [1])